Blue Protocol: Star Resonance opens Closed Beta Test sign-ups for the upcoming MMORPG

  • CBT sign-ups are available in Europe, North America, and South America
  • Limited number of slots only
  • Sign-ups are open until August 14th

Following renewed interest in Blue Protocol: Star Resonance in May, the MMORPG is now conducting its inaugural Closed Beta Test across Europe, North America, and South America. At this point, I can only add it to my wishlist on Steam or Epic Games, but if you reside in these regions, you have the opportunity to apply for participation in the CBT to be among the first to play!

As an enthusiastic fan, I can’t contain my excitement as the application window for the Blue Protocol: Star Resonance beta closes on August 14th! Keeping fingers crossed, I’ll be eagerly awaiting notifications about who made the cut between August 15th and 20th. The opportunities are scarce, so here’s hoping Lady Luck smiles upon me for this chance to dive into the game before anyone else does!

As a keen enthusiast, I’d advise you to double-check all the details you enter to ensure you’re in the running for a spot. Remember, each account is allowed just one submission to maintain fairness for all participants.

Lately, it appears that we are witnessing an increase in CBTs (Closed Beta Tests), with our team participating in several ongoing projects recently. Personally speaking, I’ve been eagerly anticipating Mongil: Star Dive and Neverness to Everness, both of which have caught my interest and have me optimistic for their future success.

Very soon, we’ll have something new for Fate Trigger ready, so keep an eye out if you’re excited about mobile anime-style adventures! In the interim, feel free to indulge in the excitement by exploring Blue Protocol: Star Resonance on our official site.

Additionally, you could choose to keep yourself informed about the recent happenings by becoming part of our Twitter community or simply watch the video embedded here for a sense of the atmosphere and imagery it presents.

Read More

2025-07-25 10:48